Journal Home
Search for

Volume 12, Issue 12, Pages 1302-1309 (December 2006)


View previous. 12 of 23 View next.

Hepatic Injury following Reduced Intensity Unrelated Cord Blood Transplantation for Adult Patients with Hematological Diseases

Eiji Kusumi14Corresponding Author Informationemail address, Masahiro Kami4, Yoshinobu Kanda6, Naoko Murashige7, Kunihiko Seki2, Masayo Fujiwara1, Rikako Koyama3, Tsunehiko Komatsu8, Akiko Hori4, Yuji Tanaka4, Koichiro Yuji5, Tomoko Matsumura4, Kazuhiro Masuoka1, Atsushi Wake1, Shigesaburo Miyakoshi1, Shuichi Taniguchi1

Received 8 April 2006; accepted 28 July 2006.

Abstract 

Liver injury is a common complication in allogeneic hematopoietic stem cell transplantation. Its major causes comprise graft-versus-host disease (GVHD), infection, and toxicities of preparative regimens and immunosuppressants; however, we have little information on liver injuries after reduced intensity cord blood transplantation (RICBT). We reviewed medical records of 104 recipients who underwent RICBT between March 2002 and May 2004 at Toranomon Hospital. Preparative regimen and GVHD prophylaxis comprised fludarabine/melphalan/total body irradiation and cyclosporine or tacrolimus. We assessed the etiology of liver injuries based on the clinical presentation, laboratory results, comorbid events, and imaging studies in 85 patients who achieved primary engraftment. The severity of liver dysfunction was assessed according to the National Cancer Institute Common Toxicity Criteria version 2.0. Hyperbilirubinemia was graded according to a report by Hogan et al (Blood. 2004;103:78-84). Moderate to very severe liver injuries were observed in 36 patients. Their causes included cholestatic liver disease (CLD) related to GVHD or sepsis (n = 15), GVHD (n = 7), cholangitis lenta (n = 5), and others (n = 9). Median onsets of CLD, GVHD, and cholangitis lenta were days 37, 40, and 22, respectively. Frequencies of grade 3-4 alanine aminotransferase elevation were comparable across the 3 types of hepatic injuries. Serum γ-glutamil transpeptidase was not elevated in any patients with cholangitis lenta, whereas 27% and 40% of patients with CLD and GVHD, respectively, developed grade 3-4 γ-glutamil transpeptidase elevation. Multivariate analysis identified 2 risk factors for hyperbilirubinemia; grade II-IV acute GVHD (relative risk, 2.23; 95% confidential interval, 1.11-4.47; P = .024) and blood stream infection (relative risk, 3.77; 95% confidential interval, 1.91-7.44; P = .00013). In conclusion, the present study has demonstrated that the hepatic injuries are significant problems after RICBT, and that GVHD and blood stream infection contribute to their pathogenesis.

1 Department of Hematology, Toranomon Hospital, Tokyo, Japan

2 Department of Pathology, Toranomon Hospital, Tokyo, Japan

3 Department of Gastroenterology, Toranomon Hospital, Tokyo, Japan

4 Division of Exploratory Research, Institute of Medical Science, University of Tokyo, Tokyo, Japan

5 Department of Internal Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan

6 Department of Cell Therapy and Transplantation Medicine, University of Tokyo Hospital, Tokyo, Japan

7 Hematopoietic Stem Cell Transplant Unit. National Cancer Center Hospital, Tokyo, Japan

8 Department of Hematology, Tsukuba Memorial Hospital, Tsukuba, Japan

Corresponding Author InformationCorrespondence and reprint requests: Eiji Kusumi, MD, Division of Exploratory Research, Institute of Medical Science, University of Tokyo, Tokyo 1088639 Japan.

PII: S1083-8791(06)00518-0

doi:10.1016/j.bbmt.2006.07.013


View previous. 12 of 23 View next.